Venous thromboembolism incidence and risk factors in adults with acute lymphoblastic leukemia treated with and without pegylated E. coli asparaginase-containing regimens

被引：0
|
作者：
Sarah M. Kashanian
Noa G. Holtzman
Ciera L. Patzke
Jonathan Cornu
Alison Duffy
Madhurima Koka
Sandrine Niyongere
Vu H. Duong
Maria R. Baer
Jummai Apata
Farin Kamangar
Ashkan Emadi
机构：
[1] University of Maryland School of Medicine,Department of Medicine
[2] National Cancer Institute,Immune Deficiency Cellular Therapy Program, Center for Cancer Research
[3] National Institutes of Health,Greenebaum Comprehensive Cancer Center
[4] University of Maryland School of Medicine,Department of Pharmacy
[5] University of Maryland Medical Center,Department of Pathology
[6] University of Maryland School of Pharmacy,Center for Urban Health Disparities Research and Innovation
[7] University of Maryland School of Medicine,Department of Biology, School of Computer, Mathematical, and Natural Sciences
[8] Morgan State University,Department of Pharmacology
[9] Morgan State University,undefined
[10] University of Maryland School of Medicine,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2021年 / 87卷
关键词：
Acute lymphoblastic leukemia; Pegylated-asparaginase; Pegaspargase; ALL; Venous thromboembolism;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：817 / 826
页数：9
相关论文
共 50 条
  • [41] Lower incidence of clinical allergy with PEG-asparaginase upfront versus the sequential use of native E. coli asparaginase followed by PEG-ASP in pediatric patients with acute lymphoblastic leukemia
    Mesegue, Montserrat
    Alonso-Saladrigues, Anna
    Perez-Jaume, Sara
    Comes-Escoda, Ariadna
    Dapena, Jose Luis
    Faura, Anna
    Conde, Nuria
    Catala, Albert
    Ruiz-Llobet, Anna
    Zapico-Muniz, Edgar
    Camos, Mireia
    Rives, Susana
    HEMATOLOGICAL ONCOLOGY, 2021, 39 (05) : 687 - 696
  • [42] Venous Thromboembolism and Its Risk Factors in Children with Acute Lymphoblastic Leukemia in Israel: A Population-Based Study
    Barzilai-Birenboim, Shlomit
    Nirel, Ronit
    Arad-Cohen, Nira
    Avrahami, Galia
    Ben Harush, Miri
    Barg, Assaf Arie
    Bielorai, Bella
    Elhasid, Ronit
    Gilad, Gil
    Toren, Amos
    Weinreb, Sigal
    Izraeli, Shai
    Elitzur, Sarah
    CANCERS, 2020, 12 (10) : 1 - 15
  • [43] Incidence of asparaginase-related hepatotoxicity, pancreatitis, and thrombotic events in adults with acute lymphoblastic leukemia treated with a pediatric-inspired regimen
    Christ, Trevor N.
    Stock, Wendy
    Knoebel, Randall W.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2018, 24 (04) : 299 - 308
  • [44] Avascular necrosis in older adolescents and adults with acute lymphoblastic leukemia treated with FRALLE protocols: a multicenter analysis of incidence, risk factors and morbidity
    Tan, Michelle
    Lasica, Masa
    Donati, Vanessa
    Rady, Kirsty
    Nagarethinam, Meena
    Fleming, Shaun
    Schwarer, Anthony
    Grigg, Andrew
    Ting, Stephen B.
    LEUKEMIA & LYMPHOMA, 2025,
  • [45] Cerebral sinus venous thrombosis in indian pediatric patients with acute lymphoblastic leukemia: Incidence, risk factors, and outcome
    Garg, Akanksha
    Kashyap, Rajesh
    Lal, Hira
    Mishra, Prabhakar
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2020, 41 (04) : 523 - 529
  • [46] Development of an epitope-specific assay for anti-asparaginase antibodies in serum of pediatric patients treated with E-coli asparaginase for acute lymphoblastic leukemia (ALL).
    Blau, B
    Klug-Albertsen, B
    Schroder, H
    Roehm, KH
    Muller, HJ
    BLOOD, 2003, 102 (11) : 249B - 249B
  • [47] Venous thromboembolism incidence associated with pegylated asparaginase (ASP) compared to the native L-ASP: A retrospective analysis with an ASP-based protocol in adult patients with acute lymphoblastic leukaemia
    Chen, RuiQi
    Atenafu, Eshetu G.
    Seki, Jack
    Liu, Xing
    Chan, Steven
    Gupta, Vikas
    Maze, Dawn
    Shuh, Andre C.
    Minden, Mark D.
    Yee, Karen
    Schimmer, Aaron D.
    Sibai, Hassan
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 201 (04) : 645 - 652
  • [48] Comparing osteonecrosis clinical phenotype, timing, and risk factors in children and young adults treated for acute lymphoblastic leukemia
    Mogensen, Signe Sloth
    Harila-Saari, Arja
    Makitie, Outi
    Myrberg, Ida Hed
    Niinimaki, Riitta
    Vestli, Anne
    Hafsteinsdottir, Solveig
    Griskevicius, Laimonas
    Saks, Kadri
    Hallbook, Helene
    Retpen, Jens
    Helt, Louise Rold
    Toft, Nina
    Schmiegelow, Kjeld
    Frandsen, Thomas Leth
    PEDIATRIC BLOOD & CANCER, 2018, 65 (10)
  • [49] RISK FACTORS ASSOCIATED WITH L-ASPARAGINASE-INDUCED PANCREATITIS IN MEXICAN PEDIATRIC PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA TREATED IN THE REMISSION INDUCTION
    Castelan Martinez, Osvaldo
    Velazquez-Tolentino, Luis
    Rivas Ruiz, Rodolfo
    Betanzos-Cabrera, Yadira
    Palomo-Colli, Miguel
    PEDIATRIC BLOOD & CANCER, 2023, 70
  • [50] Asparaginase Erwinia chrysanthemi as a component of a multi-agent chemotherapeutic regimen for the treatment of patients with acute lymphoblastic leukemia who have developed hypersensitivity to E. coli-derived asparaginase
    Figueiredo, Lisa
    Cole, Peter D.
    Drachtman, Richard A.
    EXPERT REVIEW OF HEMATOLOGY, 2016, 9 (03) : 227 - 234
12345